查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466346

体外膜氧合装置市场：按模式、年龄、组件、应用和最终用户 - 2024-2030 年全球预测

Extracorporeal Membrane Oxygenation Machine Market by Modality (Arteriovenous ECMO, Venoarterial ECMO, Venovenous ECMO), Age (Adult, Neonate, Pediatric), Component, Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

体外膜氧合装置市场规模预估2023年为7.9486亿美元，2024年达8.3214亿美元，预估2030年将达10.8563亿美元，复合年增长率为4.55%。

体外膜氧合是医疗设备为心臟和肺部无法交换足够气体维持生命的患者提供长期的心臟和呼吸支持。这些机器从患者体内抽取血液，使其通过氧合器（膜），提供氧气并去除二氧化碳，然后将其返回患者的血液中。这种外部生命维持系统接管心臟和肺部的功能，使这些器官在严重疾病期间得到休息和恢復。心血管和呼吸系统疾病的迅速增加以及改善患者治疗效果的技术进步导致 ECMO 系统的采用越来越多。此外，医疗基础设施的改善和医疗费用的上涨也促进了市场的扩张。 ECMO 程序相关的高成本以及接受过操作这些机器培训的医疗专业人员数量有限，为市场成长带来了挑战。也就是说，ECMO 设备设计的进步提高了各种治疗环境中的便携性和易用性，预计将为市场提供机会。此外，ECMO 与其他体外疗法相结合，专注于扩大 ECMO 支持适应症的研究活动预计将推动市场发展。

主要市场统计
基准年[2023] 7.9486亿美元
预测年份 [2024] 8.3214亿美元
预测年份 [2030] 10.8563 亿美元
复合年增长率（%） 4.55%

增加使用静脉-动脉 ECMO 来支持心臟和呼吸系统

动静脉体外膜氧气疗法(AV ECMO) 是一种较旧的 ECMO 支持方法，它利用患者的动脉和静脉血流驱动 ECMO 迴路内的血液。在 AV ECMO 中，血液从动脉抽出，氧合后回到静脉。该过程依赖患者的心臟透过氧合器泵血。近年来，随着技术进步在效率和安全性方面有利于其他治疗方式，ECMO 治疗已变得不那么常见。静脉动脉体外膜氧合 (VA ECMO) 透过抽取静脉血并将在体外氧合的血液重新註入动脉，支持心臟和呼吸。 VA ECMO 用于治疗严重心臟衰竭或心臟麻痹的情况，因为它绕过心臟和肺部，为这些器官提供完整的支持。插管通常透过大的中央静脉进行，例如股动脉或颈动脉。 VA ECMO 主要用于呼吸支持；血液从大静脉中取出，透过 ECMO 迴路充氧，然后返回静脉。当肺部因急性呼吸窘迫症候群(ARDS) 或肺炎等情况严重受损时，此 ECMO 模式可确保足够的氧气供应。 VV ECMO 的典型插管部位是颈内静脉和股静脉。

年龄：由于呼吸系统疾病和心臟病，对成人 ECMO 设备的需求增加

需要 ECMO 治疗的成年患者患有严重的呼吸系统或心臟疾病，对常规治疗没有反应。这包括急性呼吸窘迫症候群(ARDS)、心源性休克和肺动脉栓塞等疾病。成人 ECMO 设备旨在透过可承受长期使用的耐用组件来管理更大的血流量。由于先天性疝气或湄公河误吸症候群等出生时的情况，新生儿需要 ECMO 支持。新生儿 ECMO 设备旨在透过精确控制和温和的流量来处理新生儿微妙和最小的血量，最大限度地减少溶血和其他血液相关併发症的风险。新生儿 ECMO 设备的主要特点是注重减少侵入性并根据患者体型限制体外迴路的数量。新生儿 ECMO 设备比用于年龄较大的儿童和成人的设备具有较小的插管和专门的电路。儿童患者，从婴幼儿到年龄较大的儿童，可能需要 ECMO 来治疗对标准治疗无反应的各种呼吸和心臟衰竭病症。儿童用ECMO 设备必须具有多功能性，可调节流量和氧合器尺寸，以适应该群体中不同年龄和体型的患者。

组件：ECMO 设备对耐用且生物相容性氧合器的需求不断增加

抗凝血系统对于 ECMO 设定至关重要，可防止血液通过 ECMO 迴路并流出体外时发生凝结。 ECMO机器中的混合器将空气和纯氧混合，控制氧气浓度并将其输送给患者。混合器必须能够调节氧气浓度范围以满足不同患者的需求。插管是病患与 ECMO 设备之间的血流导管，有多种尺寸和材质可供选择，以满足特定病患的解剖结构和手术要求。热交换器对于 ECMO 治疗期间调节血液温度和维持患者体温非常重要。监测系统对于监测患者生命征象和 ECMO 机器性能非常重要。氧合器是 ECMO 机器的心臟，在这里进行气体交换。製造商现在生产的氧合器可以最大限度地提高气体交换效率，同时最大限度地减少血液创伤。帮浦透过 ECMO 迴路泵送血液，离心式帮浦和滚子泵是 ECMO 机器中的两种主要泵。离心式帮浦因其低溶血率而受到青睐，滚子泵因其简单性和成本效益而受到青睐。

用途体外心肺復苏术 (ECPR) 越来越多地用于快速恢復重要器官的氧血流。

ECMO 设备广泛用于心臟应用，作为严重心臟衰竭患者和高风险心血管手术期间生命支持的桥樑。以这种方式使用时，ECMO设备接管心臟的功能，为血液供氧并维持全身循环，让患者的心臟有时间休息和恢復或修復。这在心臟切开或心臟移植后的心源性休克期间尤其重要，因为心臟可能无法立即维持循环。体外心肺復苏术 (ECPR) 是一种新技术，在心臟麻痹的情况下，特别是当标准復苏努力无法恢復自然循环时，将 ECMO 与传统 CPR 结合使用。 ECPR 可以快速恢復重要器官的氧血流量，延长成功復苏的时限，并降低因长期缺氧而造成神经病变的风险。在可以快速部署的环境中，ECMO 是一个有价值的选择，例如心臟中心，时间敏感的干预措施对患者的生存至关重要。在呼吸系统应用中，ECMO 是一种重要的治疗工具，适用于患有严重、可逆性呼吸衰竭且对常规治疗（包括机械通气）无反应的患者。急性呼吸窘迫症候群(ARDS)、严重肺炎和肺动脉栓塞等疾病可能需要使用 ECMO。 ECMO系统提供充足的氧气供应并去除二氧化碳，让肺部休息，同时最大限度地减少人工呼吸器造成的肺损伤。 ECMO 系统在严重呼吸道疾病的管理中发挥着至关重要的作用，包括在新型流感和 COVID-19 等感染疾病爆发期间。

最终用户：专用为医院加护病房开发先进的ECMO设备

门诊手术中心 (ASC) 是提供当天手术治疗的医疗机构，包括诊断和预防程序。 ASC 对 ECMO 设备的偏好是基于在复杂手术期间和术后立即为高风险患者提供快速呼吸和心臟支持的需要。这包括预计仅需要短期 ECMO 支援的患者或具有无需长时间住院即可快速解决的特定需求的患者。医院已成为 ECMO 设备的主要最终用户，因为它们提供全面且不同级别的患者照护，包括最常使用 ECMO 设备的加护病房。医院主要使用ECMO机器来治疗那些需要长期心臟和呼吸支持的患者，而传统的机械通气和药物治疗不足以满足这些患者的需求。与 ASC 或专科诊所相比，医院通常有更多的基础设施和资源来管理复杂的 ECMO 病例。专科诊所是专门提供特定医疗保健服务的门诊设施，也可能提供 ECMO 治疗。专科诊所可以使用 ECMO 机器为患有复杂但稳定的心臟或呼吸系统疾病且不需要医院大量资源的患者提供有针对性的支援。 ECMO 设备在这些环境中是首选，因为它们可以进行强化治疗，并为有特定需求的患者提供高水准的护理。

区域洞察

由于心血管和呼吸系统疾病的高发病率、完善的医疗基础设施系统以及熟练专业人员的可用性，体外膜氧合装置在美洲地区正在经历显着增长。此外，由于 COVID-19 大流行，该地区 ECMO 使用量激增，进一步推动了市场扩张。研究和开发资金的增加，加上技术的进步，使 ECMO 系统在重症加护中能力更强、更有效率、更易于使用。欧洲、中东和非洲地区的ECMO设备市场呈现稳定成长。在欧洲，医疗费用上涨、人口老化以及文明病的流行正在影响对 ECMO 的需求。在主要国家，由于先进的医疗体系和有利于医疗设备引进的政策，ECMO的引进正在取得进展。预计亚太地区 ECMO 设备将出现高速成长。经济开拓、医疗支出增加和人口基数增加是推动市场成长的关键力量。主要国家正大力投资升级医疗基础设施。此外，一些国家的医疗旅游业正在復苏，为ECMO设备市场开闢了新的途径。

FPNV定位矩阵

FPNV定位矩阵对于评估体外膜氧合装置市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对体外膜氧合装置市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.体外膜氧合装置市场规模及预测如何？

2.体外膜氧合装置市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3.体外膜氧合装置市场的技术趋势和法规结构是什么？

4.体外膜氧合装置市场主要厂商的市场占有率如何？

5.进入体外膜氧合市场的合适型态和策略性手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管和呼吸系统疾病的盛行率
      • 在新生儿护理中引入 ECMO 并扩大 ECMO 中心
    • 抑制因素
      • ECMO 设备的危险召回
    • 机会
      • ECMO设备不断进步
      • 改善全球 ECMO 设备的报销方案
    • 任务
      • ECMO 操作和维护相关的潜在复杂性
  • 市场区隔分析
    • 方式：增加使用静脉-动脉 ECMO 提供心臟和呼吸支持
    • 年龄：呼吸系统疾病和心臟病增加了成人对 ECMO 设备的需求
    • 组件：ECMO 设备对耐用且生物相容性氧气输送装置的需求不断增加
    • 应用：体外心肺復苏术 (ECPR) 的使用正在迅速增加，因为它可以快速恢復流向重要器官的含氧血流。
    • 最终用户：开发与医院加护病房专用相容的先进 ECMO 设备
  • 市场趋势分析
    • 在美洲建立医疗保健基础设施并专注于专业研究活动
    • 增加投资以改善亚太地区的医疗保健基础设施，从而增加 ECMO 设备的部署
    • 加上欧洲、中东和非洲地区 ECMO 计画和培训的扩展，评估有效性的研究工作也不断增加。
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章体外膜氧合装置市场：依方式分类

  • 动静脉ECMO
  • 静脉-动脉ECMO
  • 静脉ECMO

第七章 体外膜氧合装置市场依年龄划分

  • 成人用
  • 新生
  • 小儿科

第八章体外膜氧合装置市场：依组成部分

  • 抗凝血系统
  • 搅拌机
  • 插管
  • 热交换器
  • 监视系统
  • 氧气发生器
  • 泵浦

第九章体外膜氧合装置市场：依应用分类

  • 应用于心
  • 体外心肺復苏
  • 呼吸应用

第10章体外膜氧合装置市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 专科诊所

第十一章：北美和南美体外膜氧合装置市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第12章：亚太地区体外膜氧合装置市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第13章：欧洲、中东和非洲体外膜氧合装置市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 新南威尔斯州政府 (NSW) 移动心臟治疗创新临床试验
    • Inspira Technologies在全球最大的体外维生会议上推出INSPIRA ART系列医疗设备
    • AIIMS-R开始ECMO治疗
    • 米高梅医疗集团为儿童开设先进的 ECMO 护理设施
    • 雅培生命维持系统获得 FDA 新批准，帮助医生治疗更多严重患者
    • 日本首台ECMO设备发挥重要作用
    • 中国核准销售自主研发的 ECMO 设备用于治疗重症 COVID-19 患者

第15章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-03607F65CC95

[198 Pages Report] The Extracorporeal Membrane Oxygenation Machine Market size was estimated at USD 794.86 million in 2023 and expected to reach USD 832.14 million in 2024, at a CAGR 4.55% to reach USD 1,085.63 million by 2030.

Extracorporeal membrane oxygenation machines are medical devices that provide prolonged cardiac & respiratory support for patients whose hearts and lungs cannot provide adequate gas exchange to sustain life. These machines extract blood from the patient's body, oxygenate it through an artificial lung (the membrane), remove carbon dioxide, and then return it to the patient's bloodstream. This external life support system takes over the function of the heart and lungs, allowing these organs to rest and heal during critical illness. The surging prevalence of cardiovascular and respiratory diseases and technological advancements that improve patient outcomes have increased the adoption of ECMO systems. Additionally, improvements in healthcare infrastructure and increased healthcare spending are contributing to the market expansion. High costs associated with ECMO procedures and a limited number of trained healthcare professionals to operate these machines represent a challenge for market growth. Nevertheless, advancements in ECMO machine design to enhance portability and ease of use in different treatment settings are expected to provide opportunistic scope for the market. Moreover, ECMO integration with other extracorporeal therapies and research activities focused on expanding the indications for ECMO support is expected to boost the market.

KEY MARKET STATISTICS
Base Year [2023] USD 794.86 million
Estimated Year [2024] USD 832.14 million
Forecast Year [2030] USD 1,085.63 million
CAGR (%) 4.55%

Modality: Rising utilization of venoarterial ECMO as it provides both cardiac and respiratory support

Arteriovenous extracorporeal membrane oxygenation (AV ECMO) is an older method of ECMO support that utilizes the patient's arterial and venous blood flow to drive blood through the ECMO circuit. In AV ECMO, blood is drawn from an artery and returned to a vein after oxygenation. This technique relies on the patient's heart to pump blood through the oxygenator. It is less commonly used in modern ECMO therapy due to advancements in technology that prefer other modes for efficiency and safety. Venoarterial extracorporeal membrane oxygenation (VA ECMO) provides both cardiac and respiratory support by withdrawing venous blood, which is then oxygenated outside of the body and infused back into an artery. VA ECMO is used in cases of severe heart failure or cardiac arrest because it bypasses both the heart and the lungs, thus providing full support to these organs. The cannulation is usually done through the large central vessels, such as the femoral or carotid artery and vein. VA ECMO is utilized primarily for respiratory support, where blood is removed from a large vein, oxygenated through the ECMO circuit, and returned to a vein. This mode of ECMO ensures adequate oxygenation when the lungs are severely compromised by conditions including acute respiratory distress syndrome (ARDS) or pneumonia. The typical cannulation sites for VV ECMO include the internal jugular and femoral veins.

Age: Increasing need for ECMO machines in adults owing to respiratory & cardiac disorders

Adult patients who require ECMO therapy suffer from severe respiratory or cardiac conditions that are unresponsive to conventional management. These include conditions such as acute respiratory distress syndrome (ARDS), cardiogenic shock, or pulmonary embolism. Adult ECMO machines are designed to manage larger blood flow with durable components that can withstand extended use. Neonates require ECMO support due to conditions present at birth, such as congenital diaphragmatic hernia or meconium aspiration syndrome. Neonatal ECMO machines are designed to handle the delicate and minimal blood volume of newborns with precise control and gentle flow to minimize the risk of hemolysis or other blood-related complications. The primary distinction for neonatal ECMO machines is the focus on reducing invasiveness and limiting the extracorporeal circuit volume to suit the patient's size. The machines also have smaller cannulae and specialized circuits than those used for older children and adults. Pediatric patients, ranging from infants to older children, may require ECMO due to various respiratory and cardiac failures that are unresponsive to standard treatment. Pediatric ECMO machines must be versatile to accommodate the wide age and size range of patients in this group, with adjustability in flow rates and oxygenator sizes.

Component: Increasing need for durable and biocompatible oxygenators for ECMO machines

Anticoagulation systems are integral to the ECMO setup, preventing blood from clotting as it travels outside the body through the ECMO circuit. Blenders in ECMO machines mix air with pure oxygen, delivering controlled oxygen levels to the patient. Blenders must offer adjustable oxygen concentration ranges to cater to varying patient needs. Cannulae are conduits for blood flow between the patient and the ECMO machine, which come in various sizes and materials tailored to specific patient anatomy and surgical requirements. Heat exchangers regulate the blood temperature during ECMO therapy, crucial for maintaining the patient's core temperature. Monitoring systems are critical for overseeing the patient's vitals and the ECMO machine's performance. The oxygenator is the heart of the ECMO machine, where gas exchange occurs. Manufacturers are currently producing oxygenators that maximize gas exchange efficiency while minimizing blood trauma. The pump propels blood through the ECMO circuit, and centrifugal and roller pumps are the two primary pumps in ECMO machines. Centrifugal pumps are preferred for their lower hemolysis rates, while roller pumps are favored for their simplicity and cost-effectiveness.

Application: Proliferating usage of Extracorporeal Cardiopulmonary Resuscitation (ECPR) as it quickly restores oxygenated blood flow to vital organs

ECMO machines are widely used in cardiac applications as a life-supporting bridge for patients experiencing severe heart failure or during high-risk cardiac procedures. When used this way, the ECMO machine takes over the heart's function to oxygenate the blood and sustain systemic circulation, giving the patient's heart time to rest and recover or be repaired. This is particularly crucial during postcardiotomy cardiogenic shock or cardiac transplantation when the heart may not immediately sustain circulation. Extracorporeal Cardiopulmonary Resuscitation (ECPR) is an emerging technique where ECMO is employed alongside conventional CPR in cases of cardiac arrest, especially when the standard resuscitation efforts do not lead to a return of spontaneous circulation. ECPR can quickly restore oxygenated blood flow to vital organs, thus extending the timeframe for successful resuscitation and reducing the risk of neurological damage due to prolonged oxygen deprivation. It represents a valuable option in environments that facilitate rapid deployment, such as in specialized cardiac centers where time-sensitive interventions can be critical to patient survival. In respiratory applications, ECMO is a pivotal treatment modality for patients experiencing severe and potentially reversible respiratory failure that is not responsive to conventional management, including mechanical ventilation. Conditions including acute respiratory distress syndrome (ARDS), severe pneumonia, or pulmonary embolism may warrant the use of ECMO. The ECMO system allows the lungs to rest while minimizing ventilator-induced lung injury by providing adequate oxygenation and removing carbon dioxide. The ECMO system has played a pivotal role in managing critical respiratory conditions, including during outbreaks of infectious diseases such as the H1N1 influenza and COVID-19.

End-User: Development of advanced ECMO machines to cater to dedicated intensive care units in hospitals

Ambulatory surgical centers (ASCs) are healthcare facilities that provide same-day surgical care, including diagnostic and preventive procedures. The preference for ECMO machines in ASCs is based on the need to provide prompt respiratory or cardiac support for high-risk patients during complex surgeries or in the immediate postoperative period. This includes patients anticipated to require only a brief duration of ECMO support or those with specific needs that can be addressed rapidly without an extended hospital stay. Hospitals serve as the primary end-user segment for ECMO machines due to the comprehensive and varied levels of patient care they provide, including intensive care units where ECMO machines are most commonly utilized. Hospitals mainly use ECMO machines for patients requiring extended cardiac and respiratory support that cannot be adequately delivered through conventional ventilation or medication. Hospitals generally have greater infrastructure and resources to manage complex ECMO cases than ASCs or specialty clinics. Specialty clinics are outpatient facilities that focus on specific healthcare services, which may include providing ECMO treatment. Specialty clinics may employ ECMO machines to provide targeted support for patients with complex but stable cardiac or respiratory conditions that do not require the extensive resources of a hospital setting. The preference for ECMO machines in this setting is for a focused approach to treatment, offering advanced care to patients with specific needs.

Regional Insights

In the Americas region, extracorporeal membrane oxygenation machines have seen significant growth driven by the high incidence rates of cardiovascular and respiratory diseases, a well-established healthcare infrastructure system, and the availability of skilled professionals. Additionally, the region has seen a surge in ECMO utilization due to the COVID-19 pandemic, further fueling market expansion. Increased funding for research and development, coupled with technological advancements, continues to enhance ECMO system capabilities, making them more efficient and user-friendly for critical care adoption. The market landscape for ECMO machines in the EMEA region exhibits steady growth. In Europe, the demand for ECMO support is influenced by rising healthcare expenditures, an aging population, and the prevalence of lifestyle-associated diseases. Major economies are implementing ECMOs due to their advanced healthcare systems and policies that favor adopting medical devices. The Asia-Pacific region shows high-growth prospects for ECMO machines. Economic development, increasing healthcare expenditure, and a growing population base are pivotal forces propelling market growth. Major economies are investing heavily in upgrading their healthcare infrastructure. Moreover, the boosting medical tourism industry in some economies is also opening new avenues for the ECMO machines market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Extracorporeal Membrane Oxygenation Machine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Extracorporeal Membrane Oxygenation Machine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Extracorporeal Membrane Oxygenation Machine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abiomed, Inc., Baxter International Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corporation, Dragerwerk AG & Co. KGaA, Eurosets S.R.L., Getinge AB, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hengko Technology Co., Ltd., Inspira Technologies OXY B.H.N. Ltd., LivaNova PLC, MC3 Cardiopulmonary, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Origen Biomedical, Inc., Owgels Group, Senko Medical Instrument Mfg. Co., Ltd., Shenzhen Mindray Biomedical Electronics Co. Ltd., Technimount System, Terumo Corporation, XENIOS AG by Fresenius Medical Care AG & Co. KGaA, and ZOLL Medical Corporation by Asahi Kasei Corporation.

Market Segmentation & Coverage

This research report categorizes the Extracorporeal Membrane Oxygenation Machine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Modality
    • Arteriovenous ECMO
    • Venoarterial ECMO
    • Venovenous ECMO
  • Age
    • Adult
    • Neonate
    • Pediatric
  • Component
    • Anticoagulation Systems
    • Blender
    • Cannulae
    • Heat Exchanger
    • Monitoring Systems
    • Oxygenator
    • Pump
  • Application
    • Cardiac Application
    • Extracorporeal Cardiopulmonary Resuscitation
    • Respiratory Application
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Extracorporeal Membrane Oxygenation Machine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Extracorporeal Membrane Oxygenation Machine Market?

3. What are the technology trends and regulatory frameworks in the Extracorporeal Membrane Oxygenation Machine Market?

4. What is the market share of the leading vendors in the Extracorporeal Membrane Oxygenation Machine Market?

5. Which modes and strategic moves are suitable for entering the Extracorporeal Membrane Oxygenation Machine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cardiovascular and respiratory diseases
      • 5.1.1.2. Adoption of ECMO for neonatal care and expansion of ECMO centers
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of ECMO machines
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in ECMO machines
      • 5.1.3.2. Improving reimbursement scenario for ECMO machines worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Potential complexity associated with the operation and maintenance of ECMO
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Modality: Rising utilization of venoarterial ECMO as it provides both cardiac and respiratory support
    • 5.2.2. Age: Increasing need for ECMO machines in adults owing to respiratory & cardiac disorders
    • 5.2.3. Component: Increasing need for durable and biocompatible oxygenators for ECMO machines
    • 5.2.4. Application: Proliferating usage of Extracorporeal Cardiopulmonary Resuscitation (ECPR) as it quickly restores oxygenated blood flow to vital organs
    • 5.2.5. End-User: Development of advanced ECMO machines to cater to dedicated intensive care units in hospitals
  • 5.3. Market Trend Analysis
    • 5.3.1. Established healthcare infrastructure and focused on specialized research efforts across the Americas
    • 5.3.2. Increasing deployment of ECMO machines with rising investment for improving healthcare infrastructure across the APAC region
    • 5.3.3. Increasing research activities for evaluating effectiveness, coupled with growing ECMO programs and training in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Extracorporeal Membrane Oxygenation Machine Market, by Modality

  • 6.1. Introduction
  • 6.2. Arteriovenous ECMO
  • 6.3. Venoarterial ECMO
  • 6.4. Venovenous ECMO

7. Extracorporeal Membrane Oxygenation Machine Market, by Age

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Neonate
  • 7.4. Pediatric

8. Extracorporeal Membrane Oxygenation Machine Market, by Component

  • 8.1. Introduction
  • 8.2. Anticoagulation Systems
  • 8.3. Blender
  • 8.4. Cannulae
  • 8.5. Heat Exchanger
  • 8.6. Monitoring Systems
  • 8.7. Oxygenator
  • 8.8. Pump

9. Extracorporeal Membrane Oxygenation Machine Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiac Application
  • 9.3. Extracorporeal Cardiopulmonary Resuscitation
  • 9.4. Respiratory Application

10. Extracorporeal Membrane Oxygenation Machine Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Americas Extracorporeal Membrane Oxygenation Machine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. The Government of New South Wales (NSW)'s New Innovative Clinical Trial with Mobile Cardiac Treatment
    • 14.3.2. Inspira Technologies Unveils the INSPIRA ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference
    • 14.3.3. AIIMS-R Starts ECMO Treatment
    • 14.3.4. MGM Healthcare Inaugurates Advanced ECMO Care Facility for Children
    • 14.3.5. Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients
    • 14.3.6. First Domestic ECMO Machine to Play Vital Role
    • 14.3.7. China Grants Market Approval to Self-Developed ECMO Device for Severe COVID-19 Cases

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET RESEARCH PROCESS
  • FIGURE 2. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ARTERIOVENOUS ECMO, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ARTERIOVENOUS ECMO, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY NEONATE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY NEONATE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ANTICOAGULATION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ANTICOAGULATION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY BLENDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY BLENDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULAE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULAE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC APPLICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC APPLICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY APPLICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY APPLICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SI